BioSpace

FDA Probing Patient Death Linked to Takeda’s Enzyme Replacement Therapy

The regulator has received reports that a group of patients treated with Adzynma had neutralizing antibodies against the ...

Scientists Uncover a New Pain Switch That Could Transform Treatment

A newly discovered neuron-released enzyme could transform pain treatment and reveal deeper secrets of how the brain learns.

'Revolutionary' treatment gives boy with rare genetic condition chance at a normal life

Ollie Chu travelled from California in the United States to the UK earlier this year to undergo the gene therapy treatment. | ...
Science Daily

A tiny enzyme may hold the key to safer pain relief

Researchers have uncovered a surprising way the brain switches pain on, revealing that neurons can release an enzyme outside ...
Science Daily

Blocking one enzyme may break the link between alcohol and liver disease

Scientists discovered that alcohol activates a sugar-producing pathway in the body, creating fructose that may reinforce ...

'Revolutionary' treatment gives boy with genetic condition chance at normal life

Ollie Chu travelled from California in the United States to the UK earlier this year to undergo the gene therapy treatment. | ...

New on-switch for pain signaling pathway could lead to safer treatment and relief

Researchers at Tulane University, with a team of colleagues from eight other universities, have discovered a new nerve cell ...

Study investigates treatment safety in cases of late HIV diagnosis

About 40 million people worldwide are living with HIV infection. In the United Kingdom, there are approximately 100,000 people affected. If the infection is not treated, the body will eventually be ...

Boy, 3, with rare condition defies odds after world-first treatment in Manchester

A three-year-old boy with a rare condition has amazed doctors with his progress after becoming the first person in the world ...

Boy, 3, receives 'revolutionary' treatment following world-first Manchester research giving hope to others with rare condition

A three year-old boy with a rare life-limiting condition has undergone a groundbreaking new treatment developed in Manchester ...
Medscape

A 23-Month-Old With a Persistent, Severe Diaper Rash Unresponsive to Treatment

A 23-month-old with a history of Hirschsprung disease was referred for evaluation of a persistent, severe diaper rash ...

Crinetics Announces First Patient Dosed in Phase 1/2 Trial Evaluating CRN09682 for the Treatment of Neuroendocrine Tumors and Other Somatostatin Receptor 2-Expressing Tumors

Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced the first patient has been dosed in the Phase 1/2 study evaluating CRN09682 in patients with metastatic or locally advanced somatostatin ...